Advus Financial Partners’s Boston Scientific BSX Stock Holding History

Advus Financial Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,830	Closed	-$270K	–	249
2025 Q4	$270K	Sell	2,830 -529	-16%	-$51.9K	0.07%	201
2025 Q3	$328K	Sell	3,359 -199	-6%	-$20.6K	0.08%	190
2025 Q2	$382K	Sell	3,558 -244	-6%	-$24.7K	0.1%	152
2025 Q1	$384K	Buy	3,802 +177	+5%	+$17.8K	0.11%	137
2024 Q4	$324K	Buy	3,625 +481	+15%	+$42.3K	0.09%	156
2024 Q3	$263K	Sell	3,144 -83	-3%	-$6.54K	0.08%	181
2024 Q2	$249K	Buy	3,227 +111	+4%	+$8.13K	0.08%	173
2024 Q1	$213K	Buy	+3,116	New	+$200K	0.07%	190

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Advus Financial Partners's BSX Position: Q1 2026 in Review

Advus Financial Partners sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,830 shares — an estimated $270K sold.

Advus Financial Partners first reported a position in BSX in Q1 2024 and held it in 8 quarters. The position peaked at $384K in Q1 2025. 1,679 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Advus Financial Partners reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Advus Financial Partners sold 2,830 Boston Scientific shares in Q1 2026, an estimated $270K.
Advus Financial Partners first reported a position in Boston Scientific in Q1 2024 and held it in 8 quarters.
Advus Financial Partners's Boston Scientific position peaked at $384K in Q1 2025.
1,679 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Advus Financial Partners's 13F filing for Q1 2026, filed 25 Aug 2026.